163 related articles for article (PubMed ID: 33873150)
1. The role of carbohydrate antigen 125 in COVID-19.
Dökümcü E
Med Hypotheses; 2021 Jun; 151():110590. PubMed ID: 33873150
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Tajbakhsh A; Gheibi Hayat SM; Taghizadeh H; Akbari A; Inabadi M; Savardashtaki A; Johnston TP; Sahebkar A
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):345-357. PubMed ID: 32921216
[TBL] [Abstract][Full Text] [Related]
3. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia.
Ros-Lucas JA; Pascual-Figal DA; Noguera-Velasco JA; Hernández-Vicente Á; Cebreiros-López I; Arnaldos-Carrillo M; Martínez-Ardil IM; García-Vázquez E; Aparicio-Vicente M; Solana-Martínez E; Ruiz-Martínez SY; Fernández-Mula L; Andujar-Espinosa R; Fernández-Suarez B; Sánchez-Caro MD; Peñalver-Mellado C; Ruiz-López FJ
Sci Rep; 2022 Apr; 12(1):6738. PubMed ID: 35469047
[TBL] [Abstract][Full Text] [Related]
4. [Ocena związku stężenia kwasu moczowego z przebiegiem zakażenia SARS-CoV-2].
Gruszka K; Terlecki M; Klocek M; Drożdż T; Rajzer M
Pol Merkur Lekarski; 2022 Jun; 50(297):160-165. PubMed ID: 35801597
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
6. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19.
Brasen CL; Christensen H; Olsen DA; Kahns S; Andersen RF; Madsen JB; Lassen A; Kierkegaard H; Jensen A; Sydenham TV; Madsen JS; Møller JK; Brandslund I
Clin Chem Lab Med; 2021 Nov; 59(12):1988-1997. PubMed ID: 34455731
[TBL] [Abstract][Full Text] [Related]
7. Role of Cardiac Biomarkers in COVID-19: What Recent Investigations Tell Us?
Khan S; Rasool ST; Ahmed SI
Curr Probl Cardiol; 2021 Oct; 46(10):100842. PubMed ID: 33994028
[TBL] [Abstract][Full Text] [Related]
8. Cardiac biomarkers alterations in patients with SARS-CoV-2 infection.
Oikonomou E; Paraskevas T; Velissaris D
Rom J Intern Med; 2022 Mar; 60(1):6-13. PubMed ID: 34610232
[TBL] [Abstract][Full Text] [Related]
9. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19.
Qin JJ; Cheng X; Zhou F; Lei F; Akolkar G; Cai J; Zhang XJ; Blet A; Xie J; Zhang P; Liu YM; Huang Z; Zhao LP; Lin L; Xia M; Chen MM; Song X; Bai L; Chen Z; Zhang X; Xiang D; Chen J; Xu Q; Ma X; Touyz RM; Gao C; Wang H; Liu L; Mao W; Luo P; Yan Y; Ye P; Chen M; Chen G; Zhu L; She ZG; Huang X; Yuan Y; Zhang BH; Wang Y; Liu PP; Li H
Hypertension; 2020 Oct; 76(4):1104-1112. PubMed ID: 32673499
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
12. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Shi X; Chen M; Zhang Y
Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
[TBL] [Abstract][Full Text] [Related]
13. Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.
Muthyala A; Sasidharan S; John KJ; Lal A; Mishra AK
World J Virol; 2022 Sep; 11(5):375-390. PubMed ID: 36188743
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate antigen 125: a new biomarker in heart failure.
Vizzardi E; D'Aloia A; Curnis A; Dei Cas L
Cardiol Rev; 2013; 21(1):23-6. PubMed ID: 22735832
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Biomarker Abnormalities Are Closely Related to Prognosis in Patients with COVID-19.
Tuo H; Li W; Tang L; He B; Yao B; Mao P; Tang Q
Int Heart J; 2021; 62(1):148-152. PubMed ID: 33518653
[TBL] [Abstract][Full Text] [Related]
16. Tumor marker response to SARS-CoV-2 infection among patients with cancer.
Gunn AH; Tashie C; Wolf S; Troy JD; Zafar Y
Cancer Med; 2022 Jul; 11(14):2865-2872. PubMed ID: 35289488
[TBL] [Abstract][Full Text] [Related]
17. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
[TBL] [Abstract][Full Text] [Related]
18. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis.
Dalia T; Lahan S; Ranka S; Acharya P; Gautam A; Goyal A; Mastoris I; Sauer A; Shah Z
Indian Heart J; 2021; 73(1):91-98. PubMed ID: 33714416
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of antigen carbohydrate 125 in heart failure.
Núñez J; Miñana G; Núñez E; Chorro FJ; Bodí V; Sanchis J
Heart Fail Rev; 2014 Sep; 19(5):575-84. PubMed ID: 23925386
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of sST2 in Acute Heart Failure and COVID-19 Infection-A Narrative Review on Pathophysiology and Clinical Prospective.
Marino L; Concistrè A; Suppa M; Galardo G; Rosa A; Bertazzoni G; Pugliese F; Letizia C; Petramala L
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
